Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2021
  2. Atrial Fibriallation and Diabetes

    Peter Rossing (Lecturer)

    14 Apr 2021

    Activity: Talk or presentationLecture and oral contribution

  3. New treatments for Diabetic Kidney Disease

    university copenhagen (Lecturer)

    14 Jan 2021

    Activity: Talk or presentationLecture and oral contribution

  4. 2020
  5. DIABETESBEHANDLING AF DEN NYRESYGE PATIENT

    Peter Rossing (Lecturer)

    20 Jan 2020

    Activity: Talk or presentationLecture and oral contribution

  6. 56th EASD Annual Meeting of the European Association for the Study of Diabetes

    Peter Rossing (Organizer)

    2020

    Activity: Participating in or organising an eventOrganisation of and participation in conference

  7. CKD in Patients With T2D

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  8. DAPA CKD background

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  9. Diabetes and atrial fibrillation

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  10. DIABETESBEHANDLING AF DEN NYRESYGE PATIENT

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  11. Empagliflozin: cardiorenal benefits in patients with type 2 diabetes, beyond glycemic control

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  12. Intervention and monitoring of diabetic nephropathy in 2020

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  13. ISN-ISE Webinar: Current management of diabetes in patients with kidney diseases

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  14. KDIGO diabetes management guideline

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  15. KDIGO DKD Guideline

    Peter Rossing (Lecturer) & Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  16. KDIGO guideline for Diabetes

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  17. KDIGO guideline for management of diabetes in CKD

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  18. leadership

    Peter Rossing (Other)

    2020 → …

    Activity: Talk or presentationLecture and oral contribution

  19. Management of Diabetes in CKD

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  20. Mechanisms That Matter: CKD and T2D.”

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  21. Metabolic Determinants of Cardiac and Renal Complications in Type 1 Diabetes

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  22. Navigating through the treatment options after metformin

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  23. New Treatment Options for Kidney Disease in Diabetes

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  24. Patient eligible for finerenone

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  25. Patient for SGLT2i

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  26. Patients with AF and Diabetes: Is it Possible to Avoid Irreversible Complications?

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  27. Recommendations for Glycemia Monitoring and Targets in CKD 

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  28. Results and Sub-Analysis of DAPA-CKD Trial

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  29. Results and Sub-Analysis of DAPA-CKD Trial

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  30. Role of SGLT2 Inhibitors for Management of Cardiorenal Syndrome in Diabetes: From Prevent to Treatment

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  31. Seeing the forest for the trees

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  32. suPAR and Complications of Diabetes Mellitus

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  33. Targeting the mineralocorticoid receptor to reduce CKD in T2D: is it time for a new treatment paradigm?

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  34. What is next after Metformin? Understanding the guidelines

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  35. Where are we now, and how should we move forward Update guideline from KDIGO 2020 DM in CKD

    Peter Rossing (Lecturer)

    2020

    Activity: Talk or presentationLecture and oral contribution

  36. 2019
  37. Linking kidney and cardiovascular complications - impact on prognosis and treatment

    Peter Rossing (Lecturer)

    14 Dec 2019

    Activity: Talk or presentationLecture and oral contribution

  38. Ecchocardiography in Diabetes and Heart Failure

    Peter Rossing (Lecturer)

    5 Dec 2019

    Activity: Talk or presentationLecture and oral contribution

  39. Management of hyperglycemia in type 2 diabetes

    Peter Rossing (Consultant)

    5 Dec 2019

    Activity: Consultancy

  40. GLP 1 in diabetic kidney disease

    Peter Rossing (Lecturer)

    4 Dec 2019

    Activity: Talk or presentationLecture and oral contribution

  41. Pathophysiology of diabetic kidney disease

    Peter Rossing (Lecturer)

    27 Nov 2019

    Activity: Talk or presentationLecture and oral contribution

  42. EASD Scientist training course 2019

    Peter Rossing (Organizer)

    18 Nov 2019

    Activity: Participating in or organising an eventOrganisation of and participation in conference

  43. KDIGO guideline on Diabetic Nephropathy

    Peter Rossing (Lecturer)

    17 Oct 2019

    Activity: Talk or presentationLecture and oral contribution

  44. Diabetic Kidney Disease

    Peter Rossing (Lecturer)

    11 Oct 2019

    Activity: Talk or presentationLecture and oral contribution

  45. Diabetic Nephropathy

    Peter Rossing (Lecturer)

    7 Oct 2019

    Activity: Talk or presentationLecture and oral contribution

  46. Diabetic Nephropathy update

    Peter Rossing (Lecturer)

    21 Sep 2019

    Activity: Talk or presentationLecture and oral contribution

  47. Metformin safety and efficacy in CKD

    Peter Rossing (Lecturer)

    19 Sep 2019

    Activity: Talk or presentationLecture and oral contribution

  48. Mechanisms of Kidney Disease Progression: Understanding the role of inflammation and fibrosis

    Peter Rossing (Lecturer)

    16 Sep 2019

    Activity: Talk or presentationLecture and oral contribution

  49. Steering group member

    Peter Rossing (Consultant)

    1 Aug 201931 Jan 2021

    Activity: Consultancy

  50. Diabetic kidney disease: Learnings so far

    Peter Rossing (Lecturer)

    14 Jun 2019

    Activity: Talk or presentationLecture and oral contribution

Previous 1 2 Next

ID: 50137657